Calculus Capital and Foresight Group have successfully sold Mologic Limited, a world leading innovator in lateral flow and rapid diagnostic technologies, and founder of Global Access Diagnostics. Mologic’s co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test, the world’s first commercial application of lateral flow technology.

Elestial Limited, an Oxfordshire-based start-up, has signed up to the national SPRINT business support programme to collaborate with the University of Surrey on a new project focused on orbital debris removal. SPRINT funding will enable Elestial to conduct a new feasibility study with Surrey Space Centre's STAR LAB to evaluate its orbital platform concept and assess design requirements for suitable deployment in various orbital applications.

Keensight Capital, one of the leading private equity managers dedicated to pan-European Growth Buyout1 investments, has entered into an agreement to sell, alongside the founder, its stake in ASTI, a leading global autonomous mobile robotics (AMR) manufacturer, to ABB.

Foresight Group LLP, an award-winning listed infrastructure and regional private equity investment manager, has sold Mologic Limited, a World leading innovator in lateral flow and rapid diagnostic technologies and founder of Global Access Diagnostics. Mologic’s co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test, the world’s first commercial application of lateral flow technology.

Data self-sovereignty is fundamental to a company’s resilience and yet communication platforms, like Whatsapp and Signal, are not sufficient for organisations compliantly handling sensitive information on a daily basis. Worldr is building a new type of communications and messaging platform built around privacy, security and data protection in team communication without compromising usability. It has now announced a $3million seed investment from some of the biggest names in deep tech, defence and finance as it heads into public launch later this year.

Ntropy, a company removing data barriers to understand financial transactions, has announced a $3.2M seed round led by QED Investors, who has previously invested in fintech unicorns Nubank, Klarna, and Current. Ntropy’s API enables businesses to convert raw data into contextualised and structured information understood by both man and machine.  January Ventures also participated in the investment round, along with founders and executives from Ramp, Square and Stripe.

TravelPerk cofounder launches mental health startup Oliva backed by Moonfire Ventures.

Viracoat, a subsidiary of Viracorp set up to develop and produce PPE that begins killing COVID-19 and other viruses on contact, has raised £2million ($4million Australian dollars) to fund final stages of accreditation and further UK based research. The funding comes from J.J. Richards & Sons Pty Ltd, an Australian, family owned and operated business that provides waste management service solutions throughout Australia and New Zealand and already has a successful scientific and medical distribution subsidiary.

Sweden’s largest providers of digital healthcare, Doktor.se, has secured €29.5 million from Tencent Holdings.

AD Williams – a leading accident repair group – has received a multi-million-pound investment from BGF. The funding will be used for the partial realisation of shareholder value and to facilitate the long-term growth of the group.

London-based startup, BEPPS Snacks, has raised £400,000 investment from early-stage venture capital investors, Ascension Ventures, 

The number of first-time funding rounds into UK seed-stage startups declined for a second consecutive year in 2020, to 36 per cent below the 2018 peak for such deals, according to new research commissioned by SFC Capital.